Sunwin International Neutraceuticals, Inc. (OTCBB: SUWN), an industry leader in Chinese herbs, veterinary medicines and low calorie natural sweetener in China, announced today that the Company has entered into a partnership with Shandong University of Chinese Traditional Medicine, a leading university in research and education of Chinese traditional medicine in China, to expand its efforts in research and development for new products
Under the partnership agreement, Sunwin will set up a research fund for science and technology development at the Shandong University of Traditional Chinese Medicine with an initial investment of US$360,000. The primary purpose for the fund is to support the research projects for the development of new medicines that have true potential commercial applications. The research projects will comprise new medicine screening, laboratory research, animal test and clinical trial for fast tracking the final clearance from the government agency for sale. The fund mainly aims at developing Chinese traditional medicines to cure common, frequently occurring diseases which relate to people's physical health and well being. The key is to focus on new innovations of medicines that have yet to complete the required clinical reporting, as well as the creation of a host of new applications of Chinese traditional medicine.
In addition, both parties will establish a joint venture that will manufacture and distribute animal related products. Shandong University of Traditional Chinese Medicine will be responsible for providing technology while Sunwin will be responsible for organizing production, management and distribution. The major initiative is to produce natural, environment friendly, and non-residual animal health products and feed additives.
|
